AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, downregulation of HOTAIR played a vital role in enhancing the acquired resistance to imatinib via PI3K/AKT signaling in chronic myelogenous leukemia (CML) [34].